MAPT and Alzheimer disease: Some of the blood-based biomarkers under development for early diagnosis of AD include detection of Aβ42/40 ratios, NfL, total tau, pTau181, pTtau217, neurogranin, and aABs [29, 40, 42, 53–55, 57–59].